Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The cost of whole-genome sequencing (WGS) is decreasing rapidly as NGS technology continues to advance and the prospect of making WGS available for public health applications is becoming a reality. So far, a number of studies have demonstrated the use of WGS as an epidemiological tool for typing and controlling outbreaks of microbial pathogens. Success of these applications is hugely dependent on efficient generation of clean genetic material that is free from host DNA contamination for rapid preparation of sequencing libraries. The presence of large amounts of host DNA severely affects the efficiency of characterizing pathogens using WGS and is therefore a serious impediment to clinical and epidemiological sequencing for healthcare and public health applications. We have developed a simple enzymatic treatment method that takes advantage of the methylation of human DNA to selectively deplete host contamination from clinical samples prior to sequencing. Using malaria clinical samples with over 80% human host-DNA contamination, we show that the enzymatic treatment enriches P. falciparum DNA up to ∼9-fold and generates high quality, non-biased sequence reads covering >98% of 86,158 catalogued typable SNP loci.

Original publication

DOI

10.1128/JCM.02507-12

Type

Journal article

Journal

Journal of clinical microbiology

Publication Date

12/2012